In recent years, N. meningitidis strains with low levels of penicillin resistance have been reported in Great Britain (5), Canada (8), Spain (7, 9, 10), and elsewhere (1, 11). In these strains, the MIC of penicillin is 5-to 50-fold higher than it is in susceptible strains (6). Tentative criteria have been proposed for discriminating between strains with moderate susceptibility and those with full susceptibility to penicillin by the disk diffusion method (2, 3), but we have found no antibiotic disk sufficiently sensitive and specific to separate clearly the two bacterial populations.
Author's Reply
We appreciate Dr. Michalski's comments on our study describing the use of quantitative EIA reactivity in predicting HIV seropositivity by Western blot. We agree that the relationship between HIV antibody titer and absorbance is not directly linear, as demonstrated by George (1) . Furthermore Given the significant clinical and psychological impact of a positive diagnosis of HIV-1 infection, we do not suggest that our algorithm is currently appropriate for widespread use. We do feel that it is an approach which warrants further evaluation and which may find utility at present in situations such as the selected circumstances we suggested (e.g., epidemiologic surveys, rapid diagnosis, and resource-poor settings). REFERENCE 1 We agree that the test is useful and think that it could be the method of choice for separating penicillin-sensitive strains from penicillin-resistant strains in laboratories without facilities for agar dilution techniques.
In recent years, N. meningitidis strains with low levels of penicillin resistance have been reported in Great Britain (5) , Canada (8) , Spain (7, 9, 10) , and elsewhere (1, 11) . In these strains, the MIC of penicillin is 5-to 50-fold higher than it is in susceptible strains (6) . Tentative criteria have been proposed for discriminating between strains with moderate susceptibility and those with full susceptibility to penicillin by the disk diffusion method (2, 3), but we have found no antibiotic disk sufficiently sensitive and specific to separate clearly the two bacterial populations.
In our opinion, the oxacillin 1-pLg disk is not suitable for differentiating these populations. Thirty of 65 strains with penicillin MICs of 0.03 to 0.06 pLg/ml tested in an earlier study produced no inhibition zone around the oxacillin disk.
We studied 187 N. meningitidis isolates. None of the strains produced ,B-lactamase. Nonduplicated organisms from recently obtained clinical isolates (cerebrospinal fluid, blood cultures, or pharyngeal swabs from carriers) were maintained as stock cultures at -70°C until just before testing. Stock cultures were thawed and samples were inoculated onto plates containing 5% chocolate horse blood agar. After incubation for 20 to 24 h, isolate colonies were subcultured onto a second chocolate agar plate which was incubated for another 20 to 24 h. Growth from this plate was used to prepare inocula.
GC agar (BBL, Cockeysville, Md.) supplemented with 5% chocholate horse blood was used for classical disk diffusion, the E Test, and agar dilution.
Plates were inoculated with 5.107 CFU for classical disk diffusion and the E Test and with 104 CFU for dilution agar (the reference MIC method). All plates were incubated in 5% CO2 at 35°C for 24 h.
Of the 187 strains studied, 61 strains had penicillin MICs of -0.25 ,ug/ml by the reference agar dilution method. By the diffusion method, the penicillin 2U disk (P2) and the amdinocillin 10-,ug disk (AMD10) were useful for discriminating between penicillin-resistant and penicillin-sensitive strains, but their specificity and sensitivity were not optimal. No penicillinsensitive strain had a P2 zone of less than 22 mm in diameter or an AMD10 zone of less than 16 mm, and no penicillinresistant strain had a P2 zone of more than 27 mm or an AMD1O zone of more than 21 The overall E-test quantitative accuracy (+1 log2 dilution) was 93% compared with that of agar dilution testing. The E test was then used to perform the susceptibility tests on a 10-year sample of 102 N. meningitidis isolates, including 5 from a recent epidemic outbreak in the University of Iowa (Iowa City) community. The E test proved to be an efficient methodology for identifying common source clusters of meningococcal disease having resistance to rifampin or sulfonamides. Moreover, the data demonstrated a recent increase in penicillin MICs (MIC for 90%o of strains, 0.094 p,g/ml) and an escalation of high-level resistance to trimethoprimsulfamethoxazole (33%) and rifampin (14%). The E test should be considered a simple and accurate susceptibility method for the emerging need to test meningococci and other pathogenic neisserias. Chocolate
Mueller-Hinton agar was observed to provide the best support of growth and E-test MIC results that correlated well with results of the reference agar dilution method previously used for neisserias.
Neisseria meningitidis is a gram-negative diplococcus that produces a broad spectrum of human diseases, ranging from transient fever and bacteremia to fulminant meningococcemia and meningitis (11, 17) . In cases of severe meningococcal infection, the onset and progression of symptoms are rapid, and the end result is frequently death or a significant morbidity (11) . Moreover, meningococcal isolates have the capacity to spread rapidly from person to person, usually in relatively confined populations of young people such as college students or military recruits (11) .
Meningococci have long been considered uniformly susceptible to penicillin (11, 17) . For that reason, susceptibility testing was seldom undertaken by clinical laboratories. Recently, however, penicillin-resistant strains of N. meningitidis have begun to emerge (3-5, 7, 12-14, 16, 17) . Given the fulminant course of N. meningitidis infections and the organism's potential to cause community outbreaks of disease, rapid and accurate antimicrobial susceptibility testing plays an increasingly important role in identifying penicillinresistant isolates for introducing appropriate antimicrobial chemotherapy and prophylaxis. Moreover, antibiogram analysis using very precise quantitative methods could also be useful as an epidemiologic tool for comparing isolates from different patients in suspected outbreaks (2) .
The E test (AB Biodisk, Solna, Sweden) is a relatively new susceptibility testing method based on the diffusion of a continuous concentration gradient of an antimicrobial agent from a plastic carrier strip into an agar medium (1, 2, 8, 15) . There have been several studies evaluating the E test as a routine susceptibility testing method and comparing it with reference methods such as broth microdilution, agar dilution, and disk diffusion (1, 15) . In general, the E-testdetermined MICs have compared favorably to those from the reference methods, some investigations using fastidious species or pathogenic neisserias (8, 15 Definitions of susceptibility were as follows: for penicillin, <0.06 ,ug/ml indicated susceptibility, >0.06 to 1 ,ug/ml indicated relative resistance, and >1 ,ug/ml indicated resistance (4, 17) ; for all other antimicrobial agents, published NCCLS breakpoint definitions were utilized (9, 10) . The breakpoint MIC for penicillin-susceptible strains is approximately 10-fold less than the expected peak levels in cerebrospinal fluid in patients with meningitis (6) . Statistical analyses were performed on a computer to compare results of methods, media, and supplements. The method of least squares was utilized, and data were presented as regression equations and correlation coefficients (r). was at the widely used susceptibility breakpoint concentration of 0.06 ,ug/ml (4, 17) . Greater resistance was identified with erythromycin and trimethoprim-sulfamethoxazole, with overall susceptibilities of only 42.2 and 70.6%, respectively.
RESULTS
An extreme polarity of MICs was observed for trimethoprim-sulfamethoxazole by the E test. MICs for all trimethoprim-sulfamethoxazole-susceptible meningococci were 51.5 ,ug/ml (70.6%), in contrast to the MICs of >32 ,ug/ml for the resistant strains. MICs for all rifampin-resistant isolates were >256 ,ug/ml. Table 4 ) occurred in the University of Iowa community, while the remaining six cases were distributed sporadically throughout the state. The five University of Iowa-associated cases occurred in two different clusters. One cluster involved two students (cases 1 and 2, Table 4 ). The N. meningitidis isolates from these two patients had identical E-test antibiograms (phenotype A) and displayed a highlevel resistance to trimethoprim-sulfamethoxazole (>32 ,ug/ ml). A similar antimicrobial susceptibility profile was seen in the isolates from the 1991 University of Illinois outbreak (Table 4) , and the two Iowan patients had recently visited the University of Illinois campus for an athletic event.
The source of the second community outbreak was traced to a barroom in Iowa City. For these three isolates (cases 3 to 5, Table 4 ) E-test MICs were also nearly identical (phenotype B); however, the isolates' resistance to rifampin and pan-susceptibility to the remaining seven antimicrobial agents clearly distinguished them from the other epidemic cluster. The remaining six Iowan isolates that occurred sporadically throughout the state (two in the same town) over the same time period were all susceptible to the eight antimicrobial agents (phenotype C) tested (cases 6 to 11, Table 4 ). Variation of the E-test MIC antibiograms between isolates with the same phenotype was less than 1 log2 dilution step.
DISCUSSION
Although penicillin remains the drug of choice for serious meningococcal disease, the drug appears to be less active because of emerging penicillin-binding protein-mediated resistance (3-5, 7, 12, 13, 15, 16) . ,B-Lactamases have also been reported in meningococci, but this resistance mechanism has remained rare (3, 5) . Furthermore, widely used prophylactic agents such as sulfonamides and rifampin are not applicable to many clinical settings because of organism resistance (11, 17, 18) or other pharmacokinetic factors. These problems were confirmed in this investigation that identified (i) increased resistance to penicillin among recent isolates (84.3% susceptible), (ii) reduced activity of rifampin and trimethoprim-sulfamethoxazole against epidemic isolates, and (iii) the need for a simple susceptibility test to direct therapy, prophylaxis, and epidemiologic studies.
Penicillin-resistant or relatively penicillin-resistant isolates have been reported essentially worldwide and in some locations represent approximately one-half of all strains (4). The mechanism of resistance to the penicillins is an altered penicillin-binding protein 2 that may have been derived from a related Neisseria sp. such as N. flavescens or N. lactamica (15) . Although Campos (4) indicated that some cephalosporins and other penicillins (ampicillin and oxacillin) may also be less active against these strains, our experience with cefotaxime (MIC9Q, 0.012 ,ug/ml) and ceftriaxone (MIC90, <0.002 ,ug/ml) showed an average potency 8-to 64-fold greater than that of penicillin. Thus, the newer parenteral cephalosporins emerge as potential therapeutic agents with excellent activity and favorable pharmacokinetics.
The current prophylaxis agents such as rifampin and sulfonamide also are less usable against contemporary N. meningitidis isolates, and high-level resistance to these drugs has developed on chemoprophylaxis (18) , resulting in clinical infections. Alternative oral agents include the fluoroquinolones (ciprofloxacin MIC90, 0.008 ,ug/ml) and the newer oral cephalosporins. Ciprofloxacin was utilized for some patient contacts in the Iowa City epidemic with apparent clinical success, i.e., no development of meningococcal disease.
To identify the need for alternative therapy or prophylaxis regimens, a simple in vitro susceptibility test is a must (17) . Dilution tests for these infrequently encountered meningococcal cases or epidemics are very expensive, cumbersome, and yet to be standardized (9, 10, 17) . Attempts to modify the disk diffusion method (4) were promising but required special potency disks and several disk interpretations and have not been reproducible in other laboratories (17) .
The Centers for Disease Control and Prevention have recommended an MH broth microdilution method for laboratories wishing to test N. meningitidis isolates (17) . Alternatively, plain MH agar or chocolate MH agar dilution tests (10) could be used (17) . However, the E-test method was proven comparable to the Centers for Disease Control and Prevention (17) and NCCLS (10) methods for pathogenic neisserias. In the current study, nearly all (.95%) penicillin MICs by the E test were + 1 log2 dilution step compared to recommended agar dilution results (10, 17) . Endpoints for the E test on chocolate MH agar were easily read, the medium supported all strains tested, and a single 150-mmdiameter plate could rapidly produce the needed information for penicillin, a newer cephalosporin (cefotaxime or ceftriaxone), rifampin, a fluoroquinolone (ciprofloxacin or ofloxacin), and trimethoprim-sulfamethoxazole. Strains relatively resistant (MICs > 0.06 to 1 ,ug/ml) to penicillin (4 of the 20 strains tested) were readily categorized, and the high-level resistance to rifampin and sulfonamides was clearly defined. These results, although preliminary, strongly suggest that the E test is an accurate, efficient methodology for susceptibility testing of meningococci.
The E-test method applied to epidemiology (2) and therapeutics in the cited epidemic was valuable in defining the most active treatments, prophylaxis, and epidemic patient clusters. The preliminary antibiograms were confirmed by molecular microbiology methods using restriction digests and contour-clamped homogeneous electric field procedures (6a). The antibiogram, however, could be of limited value among the pan-susceptible strains and the emerging, more highly prevalent sulfonamide-resistant strains. The use of an E-test antibiogram and serologic typing could screen meningococcal strains for subsequent testing by the more expensive, time-consuming molecular epidemiologic procedures.
The cost of an E-test antibiogram (five drugs) would average $10.50 to $13.50 for reagents plus minimal labor costs.
